| Drug Name |
Aztreonam |
| Drug ID |
BADD_D00206 |
| Description |
A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms. |
| Indications and Usage |
For the treatment of the following infections caused by susceptible gram-negative microorganisms: urinary tract infections, lower respiratory tract infections, septicemia, skin and skin-structure infections, intra-abdominal infections, and gynecologic infections. |
| Marketing Status |
approved |
| ATC Code |
J01DF01 |
| DrugBank ID |
DB00355
|
| KEGG ID |
D00240
|
| MeSH ID |
D001398
|
| PubChem ID |
2274
|
| TTD Drug ID |
D0F2XV
|
| NDC Product Code |
24525-0025; 13538-001; 0409-0830; 54087-160; 63323-401; 63323-402; 52952-001; 0003-2570; 0003-2560; 73301-008; 13538-008; 61958-0901; 0409-0829; 13538-009 |
| UNII |
G2B4VE5GH8
|
| Synonyms |
Aztreonam | Az-threonam | Az threonam | Azthreonam | SQ-26,776 | SQ 26,776 | SQ26,776 | Urobactam | Azactam |
